GF Fund Management’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$51.6K	Hold	3,685	–	–	﹤0.01%	411
2025 Q1	$50.1K	Buy	3,685 +663	+22%	+$9.01K	﹤0.01%	421
2024 Q4	$61.6K	Buy	+3,022	New	+$61.6K	﹤0.01%	369